Status:
RECRUITING
Developing Fast Pediatric Imaging
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Dana-Farber Cancer Institute
Conditions:
Pediatric Low-grade Gliomas
Eligibility:
All Genders
Phase:
NA
Brief Summary
This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images
Detailed Description
The purpose of the study is to develop new technologies for MRI systems. The new technologies should improve MRI capabilities in terms of how sensitive, specific, and efficient they are. The overall g...
Eligibility Criteria
Inclusion
- Infants, children and adults who have been diagnosed with Low Grade Glioma
- Healthy volunteers - Children from age 0 to adults with no upper age limit or;
- Diagnosed with LGG and being treated at DFCI;
Exclusion
- Electrical implants such as cardiac pacemakers or perfusion pumps;
- Ferromagnetic implants such as aneurysm clips, surgical clips, prosthesis, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants;
- Ferromagnetic objects such as jewelry or metal clips;
- Women of childbearing age who are seeking to become pregnant, who are breastfeeding, or who suspect they may be pregnant;
- Pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions;
- Any greater than normal potential for cardiac arrest
Key Trial Info
Start Date :
April 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03761121
Start Date
April 15 2019
End Date
March 1 2028
Last Update
December 12 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02214
2
Boston Children Hospital
Boston, Massachusetts, United States, 02215
3
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215